Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 24, 2020
Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosisKeita Takeda, Hideaki Nagai, Maho Suzukawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 14, 2018
[Retrospective Study of Clinical Features and Prognosis of Pneumococcal Pneumonia Among Patients Under 65 Years of Age]Minako Saito, Nobuharu Ohshima, Nideaki Nagai, et al.
The Journal of Infection|February 25, 2020
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosisMaho Suzukawa, Keita Takeda, Shunsuke Akashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 15, 2020
IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infectionShunsuke Akashi, Maho Suzukawa, Keita Takeda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 26, 2015
Thoracoscopic examination of empyema in a patient with sparganosis mansoniKeita Takeda, Junko Suzuki, Hideaki Nagai, et al.
Kekkaku : [Tuberculosis]|November 26, 2009
[A case of tuberculosis with multiple lung nodules, abdominal lymphadenopathy, and splenomegaly]Masafumi Horie, Megumi Tarui, Fumihiro Kashizaki, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 18, 2011
Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, JapanNobuharu Ohshima, Hirotoshi Matsui, Yoshinori Matsui, et al.
Kekkaku : [Tuberculosis]|July 18, 2007
[Bone and joint tuberculosis concurrent with tuberculosis of other organs]Osamitsu Yagi, Yoshiko Kawabe, Naohiro Nagayama, et al.
Kekkaku : [Tuberculosis]|November 25, 2011
[Evaluation of tuberculosis treatment including levofloxacin (LVFX) in cases who could not continue standard regimen]Makiko Kunogi, Yoshiko Kawabe, Junko Suzuki, et al.
Pageof 6